Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CBD Global Sciences Inc. Board/Management Information 2022

Apr 27, 2022

47728_rns_2022-04-27_85e4d7f6-7c36-4df9-a4b3-8dcf5ce735ba.PDF

Board/Management Information

Open in viewer

Opens in your device viewer

51-102F3 MATERIAL CHANGE REPORT

Item 1 Name and Address of Company CBD Global Sciences Inc. (the “ Company ”) Suite 350, 255 Union Blvd. Lakewood, CO 80228

Item 2 Date of Material Change

April 14, 2022

Item 3 News Release

The news release dated April 26, 2022 was disseminated through Newsfile Corp.

Item 4 Summary of Material Change

Change of Chief Financial Officer of the Company from Alex McAulay to Glenn Dooley on April 14, 2022.

Item 5 Full Description of Material Change

5.1 Full Description of Material Change

Appointment of Glenn Dooley as Chief Financial Officer on April 14, 2022.

Mr. Dooley is a director and Chief Operating Officer of the Issuer. He was a co-founder of Strasburg Pharms, LLC, SMBT, LLC and CannaOil, Inc., all wholly owned subsidiaries of Global NV. He is also a co-founder/co-owner Broker and Operations Manager of MAC5 Mortgage, Inc. which he founded with Brad Wyatt in 2006. Mr. Dooley has an undergraduate degree in biology and brings to the team a breadth of knowledge and experience in management and finance, coupled with effectively operating in a growing entrepreneurial environment.

Alex McAulay resigned as Chief Financial Officer on April 14, 2022.

5.2 Disclosure for Restructuring Transactions

N/A

Item 6 Reliance on subsection 7.1(2) or (3) of National Instrument 51-102

N/A

Item 7 Omitted Information

None.

{00650491 v1}

  • 2 -

Item 8 Executive Officer

Brad Wyatt, Chief Executive Officer, 720-881-2541

Item 9 Date of Report

April 26, 2022

{00650491 v1}